億通科技(300211.SZ):取得一項計算機軟件著作權登記證書
格隆匯9月20日丨億通科技(300211.SZ)公佈,公司於近日取得國家版權局頒發的一項計算機軟件著作權登記證書,獲得方式為公司原始取得,軟件著作權名稱為億通衞星信號光纖傳輸系統網絡管理軟件V1.0。
該軟件實現了對衞星信號光纖傳輸系統網絡的管理,採用SNMP協議實現了對網絡裏的光接收機和光發射機設備信息的讀取、配置、故障等的管理。該軟件簡化了設備功能配置的流程,提升了網絡的運維效率,保障了網絡的安全運行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.